Search

Author/Creator Hellmuth, Johannes C

1. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Issue 12 (December 2017)

Authors:
Eichenauer, Dennis A; Plütschow, Annette; Kreissl, Stefanie; Sökler, Martin; Hellmuth, Johannes C; Meissner, Julia; Mathas, Stephan; Topp, Max S; Behringer, Karolin; Klapper, Wolfram; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Fuchs, Michael; Diehl, Volker; Engert, Andreas; Borchmann, Peter
Journal:
Lancet oncology
Issue:
Volume 18:Issue 12(2017:Dec.)
Page Start:
1680
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test. Issue 2 (14th April 2022)

Authors:
Roessler, Johannes; Pich, Dagmar; Albanese, Manuel; Wratil, Paul R; Krähling, Verena; Hellmuth, Johannes C; Scherer, Clemens; von Bergwelt-Baildon, Michael; Becker, Stephan; Keppler, Oliver T; Brisson, Alain; Zeidler, Reinhard; Hammerschmidt, Wolfgang
Editors:
Brenner, David
Journal:
PNAS nexus
Issue:
Volume 1:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search